Davis is a graduate of Harvard Medical School and had his postgraduate medical training at Albert Einstein College of Medicine and the NIH. His academic positions have included Chair, Department of Medicine, Albany Medical College. He has served as President, American Thyroid Association, as a member of the Board of Directors of the American Board of Internal Medicine and he is Co-Head, Faculty of 1000 – Endocrinology. He serves on multiple Editorial Boards of His scientific interests include molecular mechanisms of actions of nonpeptide hormones, particularly, thyroid hormone. He and his colleagues described the cell surface receptor for thyroid hormone on integrin v3 that underlies the pro-angiogenic activity of the hormone and the proliferative action of the hormone on cancer cells. He has co-authored more than 200 original research articles and 30 textbook chapters and he has edited three medical textbooks.

Charles carried out postdoctoral fellowships at the Imperial Cancer Research Fund in London, and with Mina Bissell in California. He was awarded a Senior Research Fellowship by the Wellcome Trust to establish a laboratory at the University of Manchester. In 2005, he jointly initiated the Manchester Breast Centre to unite basic and clinical research scientists, and in 2009 he co-founded the Manchester Breakthrough Breast Cancer Research Unit. From 2009 to 2014, he was the Director of the Wellcome Centre for Cell-Matrix Research, and in 2013 he was elected to become a Fellow of the Royal Society of Biology.

Stefano GUADAGNI was borne in 1955 and is Associate Professor of Surgery at University of L’Aquila, Italy. He has published more than 170 original articles in reputed journals and is serving as an editorial board member of two Journals indexed by Scopus: BMC Research Notes and World Journal Surgical Oncology.